{"symbol": "RARE", "companyName": "Ultragenyx Pharmaceutical Inc.", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.ultragenyx.com", "description": "Ultragenyx Pharmaceutical Inc is biopharmaceutical company. It is engaged identification, acquisition, development and commercialization of novel products for treatment of rare & ultra-rare diseases, with a focus on debilitating genetic diseases.", "CEO": "Emil D. Kakkis", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}